National Bank of Canada (TSE:NA) Director Raymond Bachand Purchases 179 Shares

Share on StockTwits

National Bank of Canada (TSE:NA) Director Raymond Bachand acquired 179 shares of the stock in a transaction dated Tuesday, November 19th. The stock was acquired at an average price of C$69.75 per share, for a total transaction of C$12,485.25. Following the completion of the transaction, the director now directly owns 1,944 shares of the company’s stock, valued at C$135,594.

Raymond Bachand also recently made the following trade(s):

  • On Wednesday, August 21st, Raymond Bachand acquired 185 shares of National Bank of Canada stock. The stock was acquired at an average price of C$61.17 per share, for a total transaction of C$11,316.45.

Shares of NA stock traded down C$0.01 during trading hours on Tuesday, hitting C$69.81. The stock had a trading volume of 194,838 shares, compared to its average volume of 1,149,862. National Bank of Canada has a one year low of C$54.37 and a one year high of C$69.97. The stock’s 50-day moving average price is C$67.54 and its two-hundred day moving average price is C$64.02. The stock has a market capitalization of $23.33 billion and a price-to-earnings ratio of 11.28.

National Bank of Canada (TSE:NA) last issued its earnings results on Wednesday, August 28th. The financial services provider reported C$1.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of C$1.61 by C$0.05. The firm had revenue of C$1.95 billion during the quarter, compared to the consensus estimate of C$1.95 billion. As a group, analysts forecast that National Bank of Canada will post 6.5399998 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, September 30th were issued a $0.68 dividend. This represents a $2.72 annualized dividend and a dividend yield of 3.90%. National Bank of Canada’s dividend payout ratio (DPR) is 42.00%.

Several equities analysts have recently commented on the company. Desjardins boosted their price objective on National Bank of Canada from C$64.00 to C$68.00 and gave the company a “hold” rating in a research report on Tuesday, November 5th. Eight Capital boosted their price objective on National Bank of Canada from C$63.00 to C$66.00 in a research report on Wednesday, September 4th. TD Securities boosted their price objective on National Bank of Canada from C$64.00 to C$65.00 and gave the company a “hold” rating in a research report on Thursday, August 29th. CSFB downgraded National Bank of Canada from a “neutral” rating to an “underperform” rating and lowered their price objective for the company from C$64.00 to C$62.00 in a research report on Friday, September 6th. Finally, BMO Capital Markets lowered their price objective on National Bank of Canada from C$69.00 to C$66.00 in a research report on Thursday, August 29th.

About National Bank of Canada

National Bank of Canada provides various financial products and services to retail, commercial, corporate, and institutional clients in Canada and internationally. It operates through Personal and Commercial, Wealth Management, Financial Markets, and U.S. Specialty Finance and International segments.

Recommended Story: What is a dividend reinvestment plan?

Insider Buying and Selling by Quarter for National Bank of Canada (TSE:NA)

Receive News & Ratings for National Bank of Canada Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Bank of Canada and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

FarmaTrust Price Tops $0.0007
FarmaTrust Price Tops $0.0007
Denarius  Price Hits $0.0690 on Major Exchanges
Denarius Price Hits $0.0690 on Major Exchanges
Mobius Price Tops $0.0048
Mobius Price Tops $0.0048
Head to Head Analysis: Tennant  versus Evoqua Water Technologies
Head to Head Analysis: Tennant versus Evoqua Water Technologies
Constellation Pharmaceuticals Inc  Expected to Announce Earnings of -$0.72 Per Share
Constellation Pharmaceuticals Inc Expected to Announce Earnings of -$0.72 Per Share
Zacks: Brokerages Expect Lamb Weston Holdings Inc  Will Post Earnings of $0.85 Per Share
Zacks: Brokerages Expect Lamb Weston Holdings Inc Will Post Earnings of $0.85 Per Share


© 2006-2019 Ticker Report